BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17405776)

  • 21. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
    Kimura K; Iguchi Y; Yamashita S; Shibazaki K; Kobayashi K; Inoue T
    J Neurol Sci; 2008 Apr; 267(1-2):57-61. PubMed ID: 17964602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
    Jahan R; Vinuela F
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obstacles to the use of intravenous tissue plasminogen activator for acute ischemic stroke. Is time the only barrier?
    Laloux P; Thijs V; Peeters A; Desfontaines P
    Acta Neurol Belg; 2007 Dec; 107(4):103-7. PubMed ID: 18416282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 25. [Thrombolytic therapy in cerebral infarction].
    Varga V; Waje-Andreassen U; Naess H; Lundstadsveen MT; Thomassen L
    Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2214-7. PubMed ID: 19898567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
    Takeuchi S; Wada K; Nagatani K; Otani N; Osada H; Nawashiro H
    Acta Neurochir (Wien); 2012 Jan; 154(1):87. PubMed ID: 22037979
    [No Abstract]   [Full Text] [Related]  

  • 27. Comment on "Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008".
    Sharma VK; Teoh HL; Chan BP
    J Clin Neurosci; 2010 Apr; 17(4):543-4. PubMed ID: 20167497
    [No Abstract]   [Full Text] [Related]  

  • 28. Reperfusion seizures: a manifestation of cerebral reperfusion injury after administration of recombinant tissue plasminogen activator for acute ischemic stroke.
    Hafeez F; Razzaq MA; Levine RL; Ramirez MA
    J Stroke Cerebrovasc Dis; 2007; 16(6):273-7. PubMed ID: 18035246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fatal massive hemoptysis during thrombolysis of acute ischemic stroke].
    de la Torre-Laviana FJ; Redondo L; Antunez-Infante A; Alvarez-Marquez E
    Rev Neurol; 2006 Oct 16-31; 43(8):510-1. PubMed ID: 17033985
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network.
    Dowlatshahi D; Hakim A; Fang J; Sharma M;
    Int J Stroke; 2009 Oct; 4(5):328-34. PubMed ID: 19765119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous thrombolysis in patients older than age 80 years.
    Longstreth WT; Tirschwell DL
    Stroke; 2010 Oct; 41(10):e580; author reply e581. PubMed ID: 20798362
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombolytic therapy with alteplase for ischaemic stroke.
    Drug Ther Bull; 2009 Feb; 47(2):14-8. PubMed ID: 19193701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit.
    Yoneda Y; Yamamoto S; Hara Y; Ohta K; Matsushita M; Yamamoto D; Yamashita H; Hosoda K
    Clin Neurol Neurosurg; 2007 Sep; 109(7):567-70. PubMed ID: 17573188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke--a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia.
    Ad Hoc Committee representing the National Stroke Foundation and the Stroke Society of Australasia
    Intern Med J; 2009 May; 39(5):317-24. PubMed ID: 19545242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
    Sobesky J; Frackowiak M; Zaro Weber O; Hahn M; Möller-Hartmann W; Rudolf J; Neveling M; Grond M; Schmulling S; Jacobs A; Heiss WD
    Cerebrovasc Dis; 2007; 24(1):56-65. PubMed ID: 17519545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombolysis in acute ischaemic stroke.
    Barer D
    Lancet; 2012 Sep; 380(9847):1054; author reply 1054-5. PubMed ID: 22998709
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombolysis in acute ischaemic stroke.
    Curtis D
    Lancet; 2012 Sep; 380(9847):1054; author reply 1054-5. PubMed ID: 22998707
    [No Abstract]   [Full Text] [Related]  

  • 39. Thrombolysis in acute ischaemic stroke.
    Fatovich DM; MacDonald SP; Brown SG
    Lancet; 2012 Sep; 380(9847):1053; author reply 1054-5. PubMed ID: 22998706
    [No Abstract]   [Full Text] [Related]  

  • 40. Thrombolysis in acute ischaemic stroke.
    Newman DH; Shreves AE
    Lancet; 2012 Sep; 380(9847):1053-4; author reply 1054-5. PubMed ID: 22998705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.